Nurix Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | -113.3% | – | – | – | – | – | |
| – | -21.2% | -7.4% | +179.0% | +77.7% | +26.3% | +20.3% | +14.8% | |
| – | +18.3% | +743.3% | +267.4% | +78.0% | +19.7% | +0.8% | +11.9% | |
| – | +464.8% | +1,040.6% | +285.5% | +60.7% | – | – | – | |
| – | – | +86.3% | -75.0% | -308.7% | – | -191.5% | – | |
| – | +3.5% | +175.8% | +24.3% | +116.3% | -31.4% | +10.4% | +51.0% | |
| – | -78.8% | -3,093.7% | -57.4% | – | +151.1% | -477.3% | – | |
| – | +700.0% | -56.3% | -85.7% | – | – | – | – | |
| – | -76.2% | +268,966.7% | -54.6% | -23.8% | -97.3% | +14,996.9% | -50.9% | |
| – | +4.3% | +816.4% | -145.8% | – | – | – | +147.5% | |
| – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.